Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guilford (GLFD) - Steadily Rising -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (426)	12/21/2002 1:38:20 PM
From: scaram(o)uche	Respond to of 496

Neuropharmacology 2002 Sep;43(3):348-56 NAALADase (GCP II) inhibition prevents cocaine-kindled seizures. Witkin JM, Gasior M, Schad C, Zapata A, Shippenberg T, Hartman T, Slusher BS. Drug Development Group, Addiction Research Center, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, USA. jwitkin@lilly.com The prediction that inhibition of NAALADase, an enzyme catalyzing the cleavage of glutamate from N-acetyl-aspartyl-glutamate, would produce antiepileptogenic effects against cocaine was tested. Cocaine kindled seizures were developed in male, Swiss-Webster mice by daily administration of 60 mg/kg cocaine for 5 days. The NAALADase inhibitor 2-(phosphonomethyl)pentanedioic acid (2-PMPA) produced dose-dependent protection (10-100 mg/kg) against both the development of seizure kindling and the occurrence of seizures during the kindling process without observable behavioral side-effects. It is not likely that 2-PMPA produced protection against cocaine kindling by altering the potency of the convulsant stimulus as daily administration of 2-PMPA did not alter the convulsant thresholds for cocaine. Lower daily doses of cocaine (40 mg/kg) did not increase the incidence of seizures but produced kindling, as evidenced by the increase in seizure susceptibility when mice were probed with a higher dose of cocaine. 2-PMPA was also effective in preventing the development of sensitization to this covert kindling process. In contrast to its efficacy against cocaine kindled seizures, 2-PMPA failed to attenuate the convulsions engendered by acute challenges with pentylenetetrazole, bicuculline, N-methyl-D-aspartate, maximal electroshock or cocaine. Similarly, acutely-administered 2-PMPA did not block cocaine seizures in fully-kindled mice. NAALADase inhibition thus provides a novel means of attenuating the development of cocaine seizure kindling. (again, I'm just poking around..... I own a few shares of GLFD, but am not, by any means, convinced that it's a good investment. I'm just going to post stuff as I find it.)

To: scaram(o)uche who wrote (426)	12/21/2002 1:47:34 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 496

United States Patent 6,479,471 Jackson , et al. November 12, 2002 -------------------------------------------------------------------------------- NAALADase inhibitors Abstract The present disclosure relates to dipeptidase inhibitors, and more particularly, to novel phosphonate derivatives, hydroxyphosphinyl derivatives, and phosphoramidate derivatives that inhibit N-Acetylated .alpha.-Linked Acidic Dipeptidase (NAALADase) enzyme activity, pharmaceutical compositions comprising such derivatives, and methods of using such derivatives to inhibit NAALADase activity, and to treat prostate diseases, especially using the compounds of the present invention for the inhibition of the growth of prostate cancer cells. -------------------------------------------------------------------------------- Inventors: Jackson; Paul F. (Bel Air, MD); Slusher; Barbara S. (Kingsville, MD); Tays; Kevin L. (Elkridge, MD); Maclin; Keith M. (Baltimore, MD) Assignee: Guilford Pharmaceuticals Inc. (Baltimore, MD) Appl. No.: 466059 Filed: December 17, 1999 (another example, turned up searching simply for "PSMA". Why am I doing this? Looking for tissue distribution of the antigen, given that there is an active program to use a PSMA vaccine. But I'm just beginning..... I don't know that the PMSA of progenics, MLNM et al. is the same PMSA of GLFD.)